Abstract
Acute Lymphoblastic Leukemia (ALL) is a disease of rapid cell proliferation. Onset and development of ALL has also been linked to a reduction in the rate of apoptosis. We aimed to study the rate of in vivo spontaneous apoptosis at baseline in predicting induction outcome for newly diagnosed ALL.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
